Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic

Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic

Batool Haider,1 Amy K O’Sullivan,1 Leona Bessonova,1 Elizabeth Keane,1 Eric Achtyes,2 Philip D Harvey,3 John M Kane,4 Stephen R Saklad,5 Jeffrey P Trotter,6 Amy Claxton,1 Tiffany Polak,1 James McGrory,1 Wahidullah Noori,1 Asia Sikora Kessler,7 Aaron Yarlas,7 Dawn Velligan8 1Alkermes, Inc, Waltham, M...

Full description

Bibliographic Details
Main Authors: Haider B, O'Sullivan AK, Bessonova L, Keane E, Achtyes E, Harvey PD, Kane JM, Saklad SR, Trotter JP, Claxton A, Polak T, McGrory J, Noori W, Sikora Kessler A, Yarlas A, Velligan D
Format: Article
Language:English
Published: Dove Medical Press 2023-03-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
telehealth
coronavirus
care management
medication adherence
Online Access:https://www.dovepress.com/changes-in-clinical-management-of-patients-with-schizophrenia-treated--peer-reviewed-fulltext-article-NDT

Internet

https://www.dovepress.com/changes-in-clinical-management-of-patients-with-schizophrenia-treated--peer-reviewed-fulltext-article-NDT

Similar Items